Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung

European Respiratory Journal

Volumn 49, Issue 4, 2017, Pages

  Hilliam, Yasmin ^e   Moore, Matthew P ^e   Lamont, Iain L ^a   Bilton, Diana ^b   Haworth, Charles S ^c   Foweraker, Juliet ^c   Walshaw, Martin J ^d   Williams, David ^e   Fothergill, Joanne L ^e   De Soyza, Anthony ^f,g   Winstanley, Craig ^e  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c PAPWORTH HOSPITAL   (United Kingdom)

^d LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BRONCHIECTASIS; CROSS INFECTION; EVOLUTIONARY ADAPTATION; GENE DELETION; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MICROBIAL DIVERSITY; MICROBIAL POPULATION DYNAMICS; NON CYSTIC FIBROSIS BRONCHIECTASIS; NONHUMAN; OBSERVATIONAL STUDY; PHENOTYPIC VARIATION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; WHOLE GENOME SEQUENCING; BIOFILM; CLINICAL TRIAL; COMPLICATION; CYSTIC FIBROSIS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTICENTER STUDY; PATHOGENICITY; PATHOPHYSIOLOGY; PHENOTYPE; PSEUDOMONAS INFECTION; SPUTUM;

VIRULENCE FACTOR;

BIOFILMS; BRONCHIECTASIS; CROSS INFECTION; CYSTIC FIBROSIS; HUMANS; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM; UNITED KINGDOM; VIRULENCE FACTORS; WHOLE GENOME SEQUENCING;

EID: 85023612992     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02108-2016     Document Type: Article

References (40)

1. De Soyza A, Brown JS, Loebinger MR, et al. Research priorities in bronchiectasis. Thorax 2013; 68: 695–696.
2. Quint JK, Millett ER, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J 2016; 47: 186–193.
3. Weycker D, Edelsberg J, Oster G, et al. Association between risk of acute exacerbations and age in patients with bronchiectasis. Chest 2005; 128: 153S-b.
4. Finch S, McDonnell MJ, Abo-Leyah H, et al. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc 2015; 12: 1602–1611.
5. Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in adults. Eur Respir J 2015; 45: 1446–1462.
6. McDonnell MJ, Jary HR, Perry A, et al. Non cystic fibrosis bronchiectasis: a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. Respir Med 2015; 109: 716–726.
7. Marvig RL, Sommer LM, Jelsbak L, et al. Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients. Future Microbiol 2015; 10: 599–611.
8. Winstanley C, O’Brien S, Brockhurst MA. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol 2016; 24: 327–337.
9. Mowat E, Paterson S, Fothergill JL, et al. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am J Respir Crit Care Med 2011; 183: 1674–1679.
10. Jorth P, Staudinger BJ, Wu X, et al. Regional isolation drives bacterial diversification within cystic fibrosis lungs. Cell Host Microbe 2015; 18: 307–319.
11. Darch SE, McNally A, Harrison F, et al. Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection. Sci Rep 2015; 5: 7649.
12. Workentine ML, Sibley CD, Glezerson B, et al. Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One 2013; 8: e60225.
13. Williams D, Evans B, Haldenby S, et al. Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections. Am J Respir Crit Care Med 2015; 191: 775–785.
14. Fothergill JL, Walshaw MJ, Winstanley C. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur Respir J 2012; 40: 227–238.
15. De Soyza A, Perry A, Hall AJ, et al. Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis. Eur Respir J 2014; 43: 900–903.
16. Haworth CS, Foweraker JE, Wilkinson P, et al. Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2014; 189: 975–982.
17. Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000; 406: 959–964.
18. Winstanley C, Langille MG, Fothergill JL, et al. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res 2009; 19: 12–23.
19. Alikhan NF, Petty NK, Ben Zakour NL, et al. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 2011; 12: 402.
20. Darling AC, Mau B, Blattner FR, et al. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res 2004; 14: 1394–1403.
21. Winsor GL, Griffiths EJ, Lo R, et al. Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database. Nucleic Acids Res 2016; 44: D646–D653.
22. Kos VN, Déraspe M, McLaughlin RE, et al. The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob Agents Chemother 2015; 59: 427–436.
23. Fischer S, Klockgether J, Morán Losada P, et al. Intraclonal genome diversity of the major Pseudomonas aeruginosa clones C and PA14. Environ Microbiol Rep 2016; 8: 227–234.
24. Stewart L, Ford A, Sangal V, et al. Draft genomes of 12 host-adapted and environmental isolates of Pseudomonas aeruginosa and their positions in the core genome phylogeny. Pathog Dis 2014; 71: 20–25.
25. Freschi L, Jeukens J, Kukavica-Ibrulj I, et al. Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium. Front Microbiol 2015; 6: 1036.
26. Franklin MJ, Nivens DE, Weadge JT, et al. Biosynthesis of the Pseudomonas aeruginosa extracellular polysaccharides, alginate, Pel, and Psl. Front Microbiol 2011; 2: 167.
27. Mougous JD, Cuff ME, Raunser S, et al. A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science 2006; 312: 1526–1530.
28. Hall AJ, Fothergill JL, McNamara PS, et al. Turnover of strains and intraclonal variation amongst Pseudomonas aeruginosa isolates from paediatric CF patients. Diagn Microbiol Infect Dis 2014; 80: 324–326.
29. Chung JC, Becq J, Fraser L, et al. Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients. J Bacteriol 2012; 194: 4857–4866.
30. Hirakata Y, Srikumar R, Poole K, et al. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med 2002; 196: 109–118.
31. Sobel ML, Neshat S, Poole K. Mutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosa. J Bacteriol 2005; 187: 1246–1253.
32. Konings AF, Martin LW, Sharples KJ, et al. Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infect Immun 2013; 81: 2697–2704.
33. Marvig RL, Damkiær S, Khademi SM, et al. Within-host evolution of Pseudomonas aeruginosa reveals adaptation toward iron acquisition from hemoglobin. mBio 2014; 5: e00966-14.
34. Colvin KM, Irie Y, Tart CS, et al. The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix. Environ Microbiol 2012; 14: 1913–1928.
35. Bjarnsholt T, Jensen PØ, Fiandaca MJ, et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 2009; 44: 547–558.
36. Kuchma SL, Brothers KM, Merritt JH, et al. BifA, a cyclic-di-GMP phosphodiesterase, inversely regulates biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J Bacteriol 2007; 189: 8165–8178.
37. An S, Wu J, Zhang LH. Modulation of Pseudomonas aeruginosa biofilm dispersal by a cyclic-di-GMP phosphodiesterase with a putative hypoxia-sensing domain. Appl Environ Microbiol 2010; 76: 8160–8173.
38. Bouffartigues E, Moscoso JA, Duchesne R, et al. The absence of the Pseudomonas aeruginosa OprF protein leads to increased biofilm formation through variation in c-di-GMP level. Front Microbiol 2015; 6: 630.
39. Records AR, Gross DC. Sensor kinases RetS and LadS regulate Pseudomonas syringae type VI secretion and virulence factors. J Bacteriol 2010; 192: 3584–3596.
40. Davies EV, James CE, Williams D, et al. Temperate phages both mediate and drive adaptive evolution in pathogen biofilms. Proc Natl Acad Sci USA 2016; 113: 8266–8271.